RT Journal
A1 Bangsberg DR, Haberer JE
T1 Lifetime hiv antiretroviral therapy adherence intervention: Timing is everything: comment on “managed problem solving for antiretroviral therapy adherence”
JF JAMA Internal Medicine
JO JAMA Internal Medicine
YR 2013
FD February 25
VO 173
IS 4
SP 306
OP 307
DO 10.1001/jamainternmed.2013.2858
UL http://dx.doi.org/10.1001/jamainternmed.2013.2858
AB 
Modern, potent antiretroviral therapy regimens can suppress human immunodeficiency virus (HIV) replication indefinitely. For those who have access to these drugs and who are able to adhere on a daily basis to these drugs, life expectancy now approaches that of individuals without HIV infection, particularly if they start therapy early.1- 2 Full lifetime viral suppression offers the potentially transformative public health benefit of reducing transmission leading to a decline in number of new HIV infections.3